Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease (or Disorder); Gynecological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Large-scale testing (Phase 3)Study completedNCT01704651
What this trial is testing

Accelerating Gastrointestinal Recovery

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Jamie N. Bakkum-Gamez 146
Testing effectiveness (Phase 2)Study completedNCT01079832
What this trial is testing

Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

Who this might be right for
Fallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more
Case Comprehensive Cancer Center 50
Early research (Phase 1)Ended earlyNCT02661815
What this trial is testing

A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Dana-Farber Cancer Institute 6
Early research (Phase 1)Study completedNCT01652794
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Who this might be right for
Leydig Cell TumorOvarian SarcomaOvarian Stromal Cancer+10 more
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01482715
What this trial is testing

Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+1 more
pharmaand GmbH 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Not applicableStudy completedNCT05961267
What this trial is testing

Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism

Who this might be right for
Arthritis, RheumatoidSpondylitis, AnkylosingLupus Erythematosus, Systemic+3 more
University Hospital, Bordeaux 318
Not applicableStudy completedNCT06412861
What this trial is testing

Propofol-ketamine or Propofol-fentanyl for Procedural Sedation in the Short-term Gynecological Case

Who this might be right for
KetamineSedationGynecologic Disease
Ondokuz Mayıs University 60
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Testing effectiveness (Phase 2)Study completedNCT01891344
What this trial is testing

Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 491
Not applicableStudy completedNCT05582135
What this trial is testing

Postoperative Analgesic Effect of Esketamine

Who this might be right for
Gynecological; Surgery (Previous), Affecting Fetus or Newborn, Due to Obstructed LaborAnalgesia
Xuanhan County People's Hospital 119
Not applicableUnknownNCT03589352
What this trial is testing

Women's Knowledges About Gynaecological Aftercare

Who this might be right for
Gynecology
University Hospital, Strasbourg, France 100
Not applicableWithdrawnNCT04139694
What this trial is testing

Improving Insulin Resistance in Gynecological Cancer Patients

Who this might be right for
Insulin Resistance
Woman's
Early research (Phase 1)Study completedNCT01831089
What this trial is testing

Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerGynecological Cancer+4 more
PharmaMar 69
Large-scale testing (Phase 3)Study completedNCT01968213
What this trial is testing

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
pharmaand GmbH 564
Not applicableStudy completedNCT02221076
What this trial is testing

Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.

Who this might be right for
Cervix CancerEndometrium CancerOvarian Cancer+1 more
Mauna Kea Technologies 16
Testing effectiveness (Phase 2)Ended earlyNCT03601897
What this trial is testing

A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Deciphera Pharmaceuticals, LLC 177
Next Page